IJROBP Journal SA-CME activity for January 1, 2022,  provides practitioners with knowledge to understand phase II clinical trial design options.

IJROBP Journal SA-CME activity for December 1, 2021, Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas following Chimeric Antigen Receptor (CAR) T-Cell Therapy, provides practitioners with knowledge needed to better interpret CAR-T therapy in lymphoma patients,

This journal activity provides practitioners with the knowledge about the current approaches to reduce pelvic radiotherapy toxicity in young patients.

IJROBP Journal SA-CME activity for November 1, 2021, provides practitioners with knowledge needed to optimize clinical decision making and prognostic estimation for patients with rectal cancer.

This journal activity provides practitioners with the knowledge about the current guidelines for management of soft tissue sarcomas.

IJROBP Journal SA-CME activity for October 1, 2021, provides practitioners with knowledge needed to optimize clinical decision making and prognostic estimation for patients with rectal cancer.

IJROBP Journal SA-CME activity for September 1, 2021, provides practitioners with knowledge regarding optimal treatment approaches in the treatment of primary mediastinal B cell lymphoma.

Advances in Radiation Oncology Journal SA-CME activity for September 1, 2021 provides practitioners with knowledge needed to appropriately administer therapeutic irradiation in patients with specific implanted devices.

IJROBP Journal SA-CME activity for August 1, 2021 provides practitioners with knowledge about how the increases in germline testing have led to an increase in the identification of ATM carriers in the breast cancer population and how the implications for radiation therapy treatment in this popula

This journal activity provides practitioners with the knowledge about the treatment efficacy and treatment cost of conventional vs altered fractionation regimens for breast cancer.